Kindu Mizan, Derseh Lemma, Gelaw Baye, Moges Feleke
Department of Medical Microbiology, College of Medicine and Health Science, University of Gondar, Gondar, P.O. Box 196, Ethiopia.
Department of Epidemiology and Biostatistics Institute of Public Health College of Medicine and Health Sciences, University of Gondar, Gondar, P.O. Box 196, Ethiopia.
Int J Microbiol. 2020 Nov 3;2020:9461901. doi: 10.1155/2020/9461901. eCollection 2020.
Studies have reported that the existence of CP bacteria in Africa, but, in general, comprehensive data about the molecular epidemiology of CP organisms are limited. Therefore, this systematic review and meta-analysis expound the pooled prevalence of CP and CP clinical isolates in Africa. It also identified the diversity of carbapenemases or their encoding genes among the isolates in Africa. Lastly, the review observed the trends of these CP isolates in Africa.
A comprehensive search was performed between July 2019 and October 2019 in the following databases: PubMed, Google Scholar, and African Journal online. The included articles were published only in English. The screening was done by two authors independently. The data extracted on Excel spreadsheet were transferred to STATA 11 software for analysis.
From a total of 1,454 articles searched, 42 articles were eligible. Most of the studies were conducted in the North Africa region. But there was no report from Central Africa. The pooled prevalence of CP and CP among the clinical specimens in Africa was 21.36% and 56.97%, respectively. OXA-23 and VIM were the most prevailing carbapenemase among and respectively. The cumulative meta-analysis revealed a relative increment of the prevalence of CP over time in Africa but it showed a higher prevalence of CP isolates across years.
The review revealed a high pooled prevalence of CP clinical isolates in Africa which needs urgent action. Moreover, the emergence of concomitant carbapenemases, especially OXA-23 + NDM among CP , was also an alarming problem.
有研究报道非洲存在碳青霉烯类耐药菌(CP),但总体而言,关于CP微生物分子流行病学的全面数据有限。因此,本系统评价和荟萃分析阐述了非洲CP及CP临床分离株的合并患病率。它还确定了非洲分离株中碳青霉烯酶或其编码基因的多样性。最后,该评价观察了非洲这些CP分离株的趋势。
于2019年7月至2019年10月在以下数据库中进行了全面检索:PubMed、谷歌学术和非洲在线期刊。纳入的文章仅以英文发表。筛选由两位作者独立完成。提取到Excel电子表格中的数据被转移到STATA 11软件进行分析。
在总共检索的1454篇文章中,有42篇符合条件。大多数研究在北非地区进行。但中部非洲没有相关报告。非洲临床标本中CP及CP的合并患病率分别为21.36%和56.97%。OXA - 23和VIM分别是CP及CP中最常见的碳青霉烯酶。累积荟萃分析显示,非洲CP的患病率随时间相对增加,但多年来CP分离株的患病率更高。
该评价显示非洲CP临床分离株的合并患病率很高,需要紧急采取行动。此外,CP中伴随碳青霉烯酶的出现,尤其是OXA - 23 + NDM,也是一个令人担忧的问题。